1. Home
  2. BHVN vs STAA Comparison

BHVN vs STAA Comparison

Compare BHVN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$10.76

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

N/A

Current Price

$17.05

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHVN
STAA
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BHVN
STAA
Price
$10.76
$17.05
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$30.36
$23.53
AVG Volume (30 Days)
2.9M
1.4M
Earning Date
03-02-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,591,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$13.50
52 Week High
$44.28
$30.81

Technical Indicators

Market Signals
Indicator
BHVN
STAA
Relative Strength Index (RSI) 45.86 25.90
Support Level $10.61 $16.94
Resistance Level $12.90 $19.54
Average True Range (ATR) 0.80 0.78
MACD -0.23 -0.11
Stochastic Oscillator 17.66 12.24

Price Performance

Historical Comparison
BHVN
STAA

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: